Daily Reporter

Refine search

Date

Any time

This month

This year

Before this year

Tumour Site

Breast Cancer
Carcinoma of Unknown Primary Site (CUP)
Central Nervous System Malignancies
Endocrine Tumours
- Adrenal Carcinoma
- Neuroendocrine Neoplasms
- Thyroid Cancer
Gastrointestinal Cancers
- Anal Cancer
- Colon and Rectal Cancer
- Gastric Cancer
- Gastro-Oesophageal Junction Cancer
- Hepatobiliary Cancers
- Oesophageal Cancer
- Pancreatic Adenocarcinoma
Genitourinary Cancers
- Malignant Germ-Cell Tumours of the Adult Male
- Penile Cancer
- Prostate Cancer
- Renal Cell Cancer
- Urothelial Cancer
Gynaecological Malignancies
- Cervical Cancer
- Endometrial Cancer
- Gestational Trophoblastic Neoplasia
- Ovarian Cancer
- Vulvar and Vaginal Cancers
Haematological Malignancies
- Leukaemias
  - Acute Lymphoblastic Leukaemia
  - Acute Myeloid Leukaemia
  - Chronic Lymphocytic Leukaemia
  - Chronic Myeloid Leukaemia
  - Hairy Cell Leukaemia
- Lymphomas
  - Follicular Lymphoma
  - Hodgkin Lymphoma
  - Large B-Cell Lymphoma
  - Mantle Cell Lymphoma
  - Marginal Zone Lymphoma
  - Peripheral T-Cell Lymphoma
  - Primary Cutaneous Lymphoma
- MDS/MPN/Others
- Multiple Myeloma
Head and Neck Cancers
Sarcoma
- Bone Sarcomas
- GIST
- Soft Tissue Sarcomas
Skin Cancers
- Basal Cell and Squamous Cell Cancers of the Skin
- Melanoma
- Merkel Cell Carcinoma
Thoracic Malignancies
- Mesothelioma
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Thymoma and Thymic Cancer

Topics

Basic Science
- Cancer Biology
- Molecular Oncology
- Tumour Immunology
Cancer Control Principles
- Cancer Care Equity Principles and Health Economics
- Cancer Intelligence (eHealth, Telehealth Technology, BIG Data)
- Fundamentals of Cancer Care Organisation
- Global Cancer Control
- Multi-Disciplinary and Multi-Professional Cancer Care
Cancer Diagnostics
- Genetic and Genomic Testing
- Laboratory Diagnostics
- Pathology/Molecular Biology
Cancer Epidemiology
- Cancer Registries
- Global Cancer Statistics
Cancer in Special Situations/ Populations
- AIDS-Associated Malignancies
- Cancer and Pregnancy
- Cancer in Adolescents and Young Adults (AYA)
- Cancer in LGBTQ Populations
- Cancer in Older Adults
- Cancer Treatment in Patients with Comorbidities
- COVID-19 and Cancer
Cancer Prevention
- Population Risk Factor
- Primary Prevention
- Secondary Prevention/Screening
Cancer Research
- Bioethical Principles and GCP
- Clinical Research
- Statistics
- Translational Research
Career Development
Emergency in Oncology
Genetic Testing and Counselling
Psychosocial Aspects of Cancer
- Communication Skills
- Patient Education and Advocacy
- Psycho-Oncology
Rare Cancers
Staging and Imaging
- Nuclear Medicine and Clinical Molecular Imaging
- Radiological Imaging
- Response Evaluation (RECIST Criteria)
- Staging Procedures
Supportive and Palliative Care
- End-of-Life Care
- Management of Systemic Therapy Toxicities
- Nutritional Support
- Supportive Care and Symptom Management
Survivorship
Therapy
- Cell-Based Therapy
- Cytotoxic Therapy
- Endocrine Therapy
- Image-Guided Therapy
- Immunotherapy
- Radiation Oncology
- Surgical Oncology
- Targeted Therapy

Congress

All congresses
ESMO Congress 2023
ESMO Asia Congress 2023
ESMO Immuno-Oncology Congress 2023
ESMO Targeted Anticancer Therapies Congress 2024
ESMO Sarcoma and Rare Cancers Congress 2024
European Lung Cancer Congress 2024
ESMO Breast Cancer 2024
ESMO Gynaecological Cancers Congress 2024
ESMO Gastrointestinal Cancers Congress 2024
ESMO Congress 2024
Molecular Analysis for Precision Oncology Congress (MAP) 2024
ESMO Asia Congress 2024
ESMO Immuno-Oncology Congress 2024
Molecular Analysis for Precision Oncology Congress (MAP) 2023
ESMO Breast Cancer 2023
ESMO Sarcoma and Rare Cancers Congress 2023
European Lung Cancer Congress 2023
ESMO Targeted Anticancer Therapies Congress 2023
ESMO Gynaecological Cancers Congress 2023
ESMO Asia Congress 2022
ESMO Immuno-Oncology Congress 2022
Molecular Analysis for Precision Oncology Congress 2022
ESMO Congress 2022
ESMO Gynaecological Cancers Congress 2022
ESMO Breast Cancer 2022

Clear all

All filters

693 results for ""

Sort by

Cancer Control Principles

Are we ready to accept uncertainty in the name of cancer care sustainability?

The sustainability of health systems is critical for achieving a durable impact on population health.

25 Feb 2021

By Dario Trapani

Cancer Research

The secret of a successful academia-industry partnership

This year’s recipient of the TAT Honorary Award Prof. Ruth Plummer, retraces the most significant milestones of her career in early phase studies

25 Feb 2021

Cancer in Special Situations/ Populations

Vaccinate cancer patients against COVID-19: experts address major uncertainties

At an ESMO Live Roundtable, a panel of experts discussed the benefits and risk of COVID-19 vaccination in patients with cancer, the practicalities of vaccinating those undergoing immunosuppressant treatment and the potential advantages and disadvantages of flexible dosing intervals.

26 Jan 2021

Therapy

Switching from intravenous to oral or subcutaneous cancer treatment: a sustainable approach?

Despite alternative modes of administering anticancer medicines have reinforced the idea that at-home cancer care may be sometimes feasible as well as preferred by patients, there are concerns about costs of and accessibility to these new opportunities.

11 Dec 2020

Cancer Prevention

Cancer screening programmes, a long road back to normal

In many countries, cancer screening activities are still suffering a complete shutdown, and according to public policy experts this may limit opportunities of a timely diagnosis especially to socio-economically vulnerable populations.

30 Oct 2020

Cancer in Special Situations/ Populations

Is COVID-19 turning back the clock for patient empowerment?

After years of progress in empowering patients with cancer to play a more active role in their care, the COVID-19 pandemic is leaving many feeling anxious with little control over if, when or how they will receive a diagnosis or treatment.

20 Oct 2020

Cancer Research

Increased bureaucracy downgrades efficiency in cancer research

Nearly 20 years since the first steps to harmonise clinical trial regulations across Europe, bureaucracy is now stifling research in oncology. A newly established ESMO Clinical Research Observatory (ECRO) Task Force identifies priorities for action.

20 Oct 2020